首页>
外国专利>
Biomarker composition of phosphatidylcholine in blood for non-invasive in vitro diagnosis of acute transplant rejection in living donor liver transplantation
Biomarker composition of phosphatidylcholine in blood for non-invasive in vitro diagnosis of acute transplant rejection in living donor liver transplantation
展开▼
机译:活体供肝移植中无创性体外诊断急性移植排斥反应的血液中磷脂酰胆碱生物标志物成分
展开▼
页面导航
摘要
著录项
相似文献
摘要
TECHNICAL FIELD The present invention relates to a blood phosphatidylcholine biomarker composition for noninvasive in vitro diagnosis of a transplantation rejection of a living liver transplantation. More particularly, the present invention relates to a biomarker for the diagnosis of acute graft rejection reaction involving phosphatidylcholine (PC) A composition for diagnosing acute graft rejection reaction comprising a composition capable of measuring the level of phosphatidylcholine as an active ingredient, a kit for diagnosing acute graft rejection reaction containing the composition, and a kit for liver transplantation Provide a way to provide information. The phosphatidylcholine biomarker of the present invention is a non-invasive diagnostic marker for rejection of transplantation. It can diagnose post-transplant liver damage early, enables customized treatment of patients such as appropriate administration of immunosuppressive drugs, It is possible to prevent socioeconomic loss caused by;
展开▼